The global chemiluminescence immunoassay (CLIA) market is experiencing robust growth, driven by the increasing demand for accurate and efficient diagnostic testing methods. The market was valued at approximately USD 7.5 billion in 2023 and is projected to reach around USD 12.3 billion by 2030, growing at a compound annual growth rate (CAGR) of about 8.4% during the...